Genprex (GNPX) Prices 7.62M Share Common Offering at $1.05/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Genprex (GNPX) Adds to Tuesday's Big Gains on FDA News; Shares Up 60%
January 22, 2020 8:33 AM ESTGenprex (NASDAQ: GNPX) adds to Tuesday gains after the company received DA Fast Track designation for its gene therapy that targets lung cancer. Shares are up 64% pre-open after gaining 219% on Tuesday.
... MoreGenprex (GNPX) Granted FDA Fast Track Designation for Gene Therapy that Targets Lung Cancer
January 21, 2020 8:01 AM ESTGenprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor... More



